.Shruti Desai
Consultant at IMS Health
links
https://in.linkedin.com/in/shruti-desai-24228b23
Summary
A
pharmaceutical industry professional, with over 7 years of experience
across various facets of the pharma industry including clinical
research, scientific writing, health economics, market research,
competitive intelligence and forecasting.
Primary skills include :
content/report writing, preparing syndicated reports and pharma domain
expertise. Strong knowledge of the pharmaceutical industry: drug
development process, regulatory landscape, company strategies (M&As,
licensing deals, product life cycle management) etc.Experience
Lead Analyst ( Market Access)
Decision Resources
Consultant
IMS Health
•
Production and delivery of highly insightful Pharmaceutical Company
Profiles which provide an in depth understanding of top pharma companies
with respect to their business strategies, financial analysis,
therapeutic and geographic areas of focus and R&D pipeline.
• Team Management: Leading a team of six members and ensuring seamless execution of all projects handled by the team. The role involves recruitment (interviews), training, work allocation, performance review and career management of team members.
• Client Relationship Management: Liaising with onshore stakeholders to understand their requirements and ensuring that their expectations are met.
• Team Management: Leading a team of six members and ensuring seamless execution of all projects handled by the team. The role involves recruitment (interviews), training, work allocation, performance review and career management of team members.
• Client Relationship Management: Liaising with onshore stakeholders to understand their requirements and ensuring that their expectations are met.
Associate Consultant (Company Intelligence Team)
IMS Health
In-depth
analyses of top pharmaceutical companies in terms of their strategic
interests on specific therapeutic sectors, particular geographic
targets, M&A interests etc.
Healthcare Analyst, Business Insights team
Datamonitor
Syndicated Report Writing:
1. Comprehensive Therapy Area Reports:• Market characterization (market sizing, epidemiology, treatment usage patterns and the key drivers and restraints) of varies therapy areas.
• Trend analysis of the therapeutic segment: Using the IMS MIDAS market segmentation data, performed the disease area evaluation and identified the interesting and unique trends in various therapy segments.
• Defining geographical landscape of therapeutic markets in the major regions: the US, the top five countries of Europe (the UK, Germany, France, Italy and Spain), and Japan.
• Drug class analysis within a therapy sector: Analyzing the drug classes using the Anatomical Therapeutic Chemical (ATC) classification of drug classes.
• Market forecasts and R&D pipeline analysis and profiling the most promising drugs.
• Defining and analyzing the competitive landscapes (mergers and acquisitions (M&A), licensing agreements and co-development deals) of varies therapy areas. Identifying and profiling the market leaders including SWOT analyses.
• Capturing the key events and analyzing their impact on the stakeholders.
2. ‘Top 10 series’ reports:
Profiling the top companies on the following parameters:
• Capturing the key events associated with the company
• Studying the company’s R&D portfolio and profiling the promising candidates in the R&D pipeline
• Profiling the company’s “Marketed Products Portfolio”
3. Specific Market Analysis Reports:
• In-depth analysis of emerging economies (Brazil, Russia, India and China) including outsourcing trends, upcoming CMOs (Contract manufacturing organizations), regulatory landscape and pricing and reimbursement scenarios in these regions.
Scientific Writer, Health Economics and Outcomes Research
Novartis
•
Writing systematic literature reviews on health economic outcomes such
as patient adherence to medication, quality of life, life years gained
etc.
• Performing literature searches (through PubMed, Embase and other databases) on HEOR related subjects.
• Prepared Global Value Dossiers which comprises the following:
-Detailed analysis of epidemiology (incidence/prevalence rates) in various therapy sectors
-Pharmacoepidemiology analysis: Studying adherence, perseverance, patient compliance in specific diseases.
-Humanistic burden and economic burden: Reviewing the Cost of care, Quality of life, Quality adjusted Life years for diseases.
-Unmet medical need: Identifying the gaps in treatment patterns.
• Performing literature searches (through PubMed, Embase and other databases) on HEOR related subjects.
• Prepared Global Value Dossiers which comprises the following:
-Detailed analysis of epidemiology (incidence/prevalence rates) in various therapy sectors
-Pharmacoepidemiology analysis: Studying adherence, perseverance, patient compliance in specific diseases.
-Humanistic burden and economic burden: Reviewing the Cost of care, Quality of life, Quality adjusted Life years for diseases.
-Unmet medical need: Identifying the gaps in treatment patterns.
Clinical Research Co-ordiinator / Nutritionist
Bangalore Diabetes Hospital
Participated in Phase III/ IV clinical trials conducted by renowned pharma companies: Pfizer, Eli Lilly, Novo Nordisk etc.
Certifications
Education
Bilcare Research Academy
Post Graduate Diploma in Clinical Trial Management, Pharmaceutical Sciences
//////////
No comments:
Post a Comment